It is based on farfetched
claims about the risks involved, and furthermore its policy «solutions» make no sense, even if those risks were accurately portrayed.
Not exact matches
Yet along with the retail investors» continuing efforts, the fallout continues; the City of Hamilton filed a statement of
claim in Ontario Superior Court in September alleging it was misled by Deutsche Bank
about the
risk involved in its purchase of $ 10 million worth of ABCP.
In their Lipitor diabetes lawsuits, the plaintiffs
claims that the drug manufacturer was aware of these side effects but did not act to make sure that the public knew
about them, too It wasn't until 2012 - six years after Lipitor entered the market - that the U.S. Food and Drug Administration demanded that manufacturers of drugs that lower cholesterol, also known as statins, modify their labeling to include some of the more dangerous
risks involved, including memory loss and diabetes.
However, research tells us that this is not the only reason: invariably it is concerns
about the costs
involved in commencing
claims as well as the
risk of liability for successful defendants» costs that prove a major deterrent.